The Challenge and Opportunity to Diagnose Parkinson's Disease in Midlife
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Challenge and Opportunity to Diagnose Parkinson's Disease in Midlife
Authors
Keywords
-
Journal
Frontiers in Neurology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-12-17
DOI
10.3389/fneur.2019.01328
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Progress of pharmacological approaches in Parkinson's disease
- (2019) Kirsten E. Zeuner et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease
- (2019) Yaping Shao et al. Molecular Neurodegeneration
- Distinct Stress Response and Altered Striatal Transcriptome in Alpha-Synuclein Overexpressing Mice
- (2019) Zinah Wassouf et al. Frontiers in Neuroscience
- Entanglement of Genetics and Epigenetics in Parkinson’s Disease
- (2019) H. J. van Heesbeen et al. Frontiers in Neuroscience
- Prodromal Parkinson's Disease: The Decade Past, the Decade to Come
- (2019) Ronald B. Postuma et al. MOVEMENT DISORDERS
- Abnormal α -synuclein deposits in skin nerves: intra- and inter-laboratory reproducibility
- (2019) V Donadio et al. EUROPEAN JOURNAL OF NEUROLOGY
- DNA methylation changes associated with Parkinson’s disease progression: outcomes from the first longitudinal genome-wide methylation analysis in blood
- (2019) Adrienne Henderson-Smith et al. Epigenetics
- The Role of LRRK2 in Neurodegeneration of Parkinson Disease
- (2018) Qin Rui et al. Current Neuropharmacology
- Environmental Enrichment Prevents Transcriptional Disturbances Induced by Alpha-Synuclein Overexpression
- (2018) Zinah Wassouf et al. Frontiers in Cellular Neuroscience
- Modeling Parkinson’s Disease in C. elegans
- (2018) Jason F. Cooper et al. Journal of Parkinsons Disease
- The Parkinson Pandemic—A Call to Action
- (2018) E. Ray Dorsey et al. JAMA Neurology
- Modeling Parkinson’s Disease in Drosophila: What Have We Learned for Dominant Traits?
- (2018) Yulan Xiong et al. Frontiers in Neurology
- Animal models of neurodegenerative diseases
- (2018) Ted M. Dawson et al. NATURE NEUROSCIENCE
- Skin α-synuclein deposits differ in clinical variants of synucleinopathy: an in vivo study
- (2018) V. Donadio et al. Scientific Reports
- Robust Ensemble Classification Methodology for I123-Ioflupane SPECT Images and Multiple Heterogeneous Biomarkers in the Diagnosis of Parkinson's Disease
- (2018) Diego Castillo-Barnes et al. Frontiers in Neuroinformatics
- Parkinson’s Disease: Biomarkers, Treatment, and Risk Factors
- (2018) Fatemeh N. Emamzadeh et al. Frontiers in Neuroscience
- SNCA overexpression disturbs hippocampal gene expression trajectories in midlife
- (2018) Thomas Hentrich et al. Aging-US
- Recent Advances in Biomarkers for Parkinson’s Disease
- (2018) Runcheng He et al. Frontiers in Aging Neuroscience
- From Prodromal to Overt Parkinson’s Disease: Towards a New Definition in the Year 2040
- (2018) Daniela Berg et al. Journal of Parkinsons Disease
- A review of genome-wide transcriptomics studies in Parkinson's disease
- (2017) Genevie Borrageiro et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- The use of nonhuman primate models to understand processes in Parkinson’s disease
- (2017) Javier Blesa et al. JOURNAL OF NEURAL TRANSMISSION
- Aging and Parkinson's disease: Different sides of the same coin?
- (2017) Timothy J. Collier et al. MOVEMENT DISORDERS
- Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
- (2017) J.A. Obeso et al. MOVEMENT DISORDERS
- A new potential biomarker for dementia with Lewy bodies
- (2017) Vincenzo Donadio et al. NEUROLOGY
- Response to comment by Juan Segura-Aguilar: New preclinical model are required to discover neuroprotective compound in Parkinson’s disease
- (2017) Giuseppina Mattace Raso et al. PHARMACOLOGICAL RESEARCH
- New preclinical model are required to discover neuroprotective compound in Parkinson’s disease
- (2017) Juan Segura-Aguilar PHARMACOLOGICAL RESEARCH
- Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson’s disease
- (2017) Hui-Fang Liu et al. Scientific Reports
- Epigenetic Biomarkers for Parkinson’s Disease: From Diagnostics to Therapeutics
- (2017) Jennifer L. Jakubowski et al. Journal of Parkinsons Disease
- Huntington's disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels
- (2016) Steve Horvath et al. Aging-US
- An update on the diagnosis and treatment of Parkinson disease
- (2016) Philippe Rizek et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- The clinical symptoms of Parkinson's disease
- (2016) Sigurlaug Sveinbjornsdottir JOURNAL OF NEUROCHEMISTRY
- Nonmotor symptoms in patients with Parkinson disease
- (2016) Tie-mei Zhang et al. MEDICINE
- The Aging Epigenome
- (2016) Lauren N. Booth et al. MOLECULAR CELL
- Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC α-synuclein transgenic rat model of Parkinson's disease
- (2016) Zacharias Kohl et al. NEUROBIOLOGY OF DISEASE
- The diagnostic discrimination of cutaneous α-synuclein deposition in Parkinson disease
- (2016) Christopher H. Gibbons et al. NEUROLOGY
- Accuracy of clinical diagnosis of Parkinson disease
- (2016) Giovanni Rizzo et al. NEUROLOGY
- Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses
- (2016) Vanesa Bellou et al. PARKINSONISM & RELATED DISORDERS
- Biomarkers in Parkinson's disease: Advances and strategies
- (2016) Marion Delenclos et al. PARKINSONISM & RELATED DISORDERS
- Behavioral epigenetics
- (2016) David S. Moore Wiley Interdisciplinary Reviews-Systems Biology and Medicine
- Genetic and environmental influences interact with age and sex in shaping the human methylome
- (2016) Jenny van Dongen et al. Nature Communications
- Genetic variants near MLST8 and DHX57 affect the epigenetic age of the cerebellum
- (2016) Ake T. Lu et al. Nature Communications
- Prodromal Markers in Parkinson’s Disease: Limitations in Longitudinal Studies and Lessons Learned
- (2016) Sebastian Heinzel et al. Frontiers in Aging Neuroscience
- Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease
- (2016) Nicholas S. Lim et al. Annals of Clinical and Translational Neurology
- Increased epigenetic age and granulocyte counts in the blood of Parkinson's disease patients
- (2015) Steve Horvath et al. Aging-US
- Methylomic trajectories across human fetal brain development
- (2015) Helen Spiers et al. GENOME RESEARCH
- Epigenetic mechanisms in Parkinson's disease
- (2015) Ya Feng et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- Prediagnostic presentations of Parkinson's disease in primary care: a case-control study
- (2015) Anette Schrag et al. LANCET NEUROLOGY
- Biomarkers of Parkinson’s disease: Present and future
- (2015) Diane B. Miller et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- MDS research criteria for prodromal Parkinson's disease
- (2015) Daniela Berg et al. MOVEMENT DISORDERS
- Time to change the blind men and the elephant approach to Parkinson disease?
- (2015) Brad A. Racette et al. NEUROLOGY
- Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases
- (2015) Miguel Chin-Chan et al. Frontiers in Cellular Neuroscience
- Meta-analyses on prevalence of selected Parkinson’s nonmotor symptoms before and after diagnosis
- (2015) Honglei Chen et al. Translational Neurodegeneration
- Cerebrospinal Fluid α-Synuclein Predicts Cognitive Decline in Parkinson Disease Progression in the DATATOP Cohort
- (2014) Tessandra Stewart et al. AMERICAN JOURNAL OF PATHOLOGY
- Prodromal features for Parkinson's disease - baseline data from the TREND study
- (2014) A. Gaenslen et al. EUROPEAN JOURNAL OF NEUROLOGY
- The Onset of Nonmotor Symptoms in Parkinson's disease (The ONSET PDStudy)
- (2014) Claustre Pont-Sunyer et al. MOVEMENT DISORDERS
- The ongoing pursuit of neuroprotective therapies in Parkinson disease
- (2014) Dilan Athauda et al. Nature Reviews Neurology
- Imaging prodromal Parkinson disease: The Parkinson Associated Risk Syndrome Study
- (2014) D. Jennings et al. NEUROLOGY
- Importance of nondopaminergic features in evaluating disease severity of Parkinson disease
- (2014) J. F. van der Heeden et al. NEUROLOGY
- The Association Between Midlife Cardiorespiratory Fitness Levels and Later-Life Dementia
- (2013) Laura F. DeFina et al. ANNALS OF INTERNAL MEDICINE
- A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats
- (2013) Silke Nuber et al. BRAIN
- Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
- (2013) Jeffrey H. Kordower et al. BRAIN
- Cross-sectional and longitudinal changes in DNA methylation with age: an epigenome-wide analysis revealing over 60 novel age-associated CpG sites
- (2013) I. Florath et al. HUMAN MOLECULAR GENETICS
- Perceived Stress Symptoms in Midlife Predict Disability in Old Age: A 28-Year Prospective Cohort Study
- (2013) J. Kulmala et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Predictors of Parkinson's disease-not quite sound
- (2013) Erwin B. Montgomery MOVEMENT DISORDERS
- Diagnostic value of minor salivary glands biopsy for the detection of Lewy pathology
- (2013) Emmanuelle Folgoas et al. NEUROSCIENCE LETTERS
- A Guide to Neurotoxic Animal Models of Parkinson's Disease
- (2013) K. Tieu Cold Spring Harbor Perspectives in Medicine
- Genetics of Parkinson's Disease
- (2013) C. Klein et al. Cold Spring Harbor Perspectives in Medicine
- Parkinson's Disease and Parkinsonism: Neuropathology
- (2013) D. W. Dickson Cold Spring Harbor Perspectives in Medicine
- DNA methylation age of human tissues and cell types
- (2013) Steve Horvath GENOME BIOLOGY
- Influence of individual and combined healthy behaviours on successful aging
- (2012) S. Sabia et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- The PRIPS study: screening battery for subjects at risk for Parkinson's disease
- (2012) D. Berg et al. EUROPEAN JOURNAL OF NEUROLOGY
- Genome-wide Methylation Profiles Reveal Quantitative Views of Human Aging Rates
- (2012) Gregory Hannum et al. MOLECULAR CELL
- Premotor Parkinson's disease: Concepts and definitions
- (2012) Andrew Siderowf et al. MOVEMENT DISORDERS
- Parkinson's disease: Evidence for environmental risk factors
- (2012) Karl Kieburtz et al. MOVEMENT DISORDERS
- 100 years of Lewy pathology
- (2012) Michel Goedert et al. Nature Reviews Neurology
- Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease
- (2011) Ivana Devic et al. BRAIN
- Projected numbers of people with movement disorders in the years 2030 and 2050
- (2011) Jan-Philipp Bach et al. MOVEMENT DISORDERS
- Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts
- (2011) Kurt A. Jellinger MOVEMENT DISORDERS
- Motor and non-motor predictors of illness-related distress in Parkinson’s disease
- (2011) Catharina Sjödahl Hammarlund et al. PARKINSONISM & RELATED DISORDERS
- The Parkinson Progression Marker Initiative (PPMI)
- (2011) Kenneth Marek et al. PROGRESS IN NEUROBIOLOGY
- Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders
- (2010) Thomas G. Beach et al. ACTA NEUROPATHOLOGICA
- Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s disease
- (2010) Kelly Del Tredici et al. ACTA NEUROPATHOLOGICA
- The Effect of Midlife Physical Activity on Cognitive Function Among Older Adults: AGES—Reykjavik Study
- (2010) Milan Chang et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Parkinson's at risk syndrome: Can Parkinson's disease be predicted?
- (2010) Matthew B. Stern et al. MOVEMENT DISORDERS
- Physical activities and future risk of Parkinson disease
- (2010) Q. Xu et al. NEUROLOGY
- Promoting Functional Health in Midlife and Old Age: Long-Term Protective Effects of Control Beliefs, Social Support, and Physical Exercise
- (2010) Margie E. Lachman et al. PLoS One
- Multiplex Analysis of Cytokines in the Serum and Cerebrospinal Fluid of Patients With Alzheimer's Disease by Color-Coded Bead Technology
- (2009) Chulhee Choi et al. Journal of Clinical Neurology
- Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria
- (2009) Dennis W Dickson et al. LANCET NEUROLOGY
- A longitudinal program for biomarker development in Parkinson's disease: A feasibility study
- (2009) Bernard Ravina et al. MOVEMENT DISORDERS
- Parkinson’s disease: genetic versus toxin-induced rodent models
- (2008) Mügen Terzioglu et al. FEBS Journal
- Parkinson's disease: clinical features and diagnosis
- (2008) J Jankovic JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Parkin Deficiency Increases Vulnerability to Inflammation-Related Nigral Degeneration
- (2008) T. C. Frank-Cannon et al. JOURNAL OF NEUROSCIENCE
- The effectiveness of exercise interventions for people with Parkinson's disease: A systematic review and meta-analysis
- (2008) Victoria A. Goodwin et al. MOVEMENT DISORDERS
- Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence
- (2008) M. Hamer et al. PSYCHOLOGICAL MEDICINE
- Recreational physical activity and risk of Parkinson's disease
- (2007) Evan L. Thacker et al. MOVEMENT DISORDERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now